nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—CYP1A2—Carmustine—brain cancer	0.176	0.285	CbGbCtD
Clarithromycin—CYP3A4—Temozolomide—brain cancer	0.133	0.215	CbGbCtD
Clarithromycin—CYP3A4—Lomustine—brain cancer	0.113	0.183	CbGbCtD
Clarithromycin—CYP3A5—Etoposide—brain cancer	0.0702	0.114	CbGbCtD
Clarithromycin—CYP1A2—Etoposide—brain cancer	0.0523	0.0845	CbGbCtD
Clarithromycin—ABCB1—Etoposide—brain cancer	0.0457	0.0739	CbGbCtD
Clarithromycin—CYP3A4—Etoposide—brain cancer	0.0274	0.0443	CbGbCtD
Clarithromycin—Troleandomycin—CYP2C9—brain cancer	0.0028	1	CrCbGaD
Clarithromycin—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00165	0.0578	CbGpPWpGaD
Clarithromycin—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.0015	0.0526	CbGpPWpGaD
Clarithromycin—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.00142	0.0497	CbGpPWpGaD
Clarithromycin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00129	0.045	CbGpPWpGaD
Clarithromycin—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00128	0.0448	CbGpPWpGaD
Clarithromycin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00117	0.041	CbGpPWpGaD
Clarithromycin—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.00103	0.0359	CbGpPWpGaD
Clarithromycin—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000987	0.0345	CbGpPWpGaD
Clarithromycin—Chills—Hydroxyurea—brain cancer	0.0009	0.00257	CcSEcCtD
Clarithromycin—Hyperhidrosis—Procarbazine—brain cancer	0.00089	0.00254	CcSEcCtD
Clarithromycin—Renal failure—Carmustine—brain cancer	0.000888	0.00254	CcSEcCtD
Clarithromycin—Stomatitis—Carmustine—brain cancer	0.00088	0.00251	CcSEcCtD
Clarithromycin—Pneumonia—Temozolomide—brain cancer	0.000878	0.00251	CcSEcCtD
Clarithromycin—Anorexia—Procarbazine—brain cancer	0.000878	0.00251	CcSEcCtD
Clarithromycin—Infestation—Temozolomide—brain cancer	0.000873	0.00249	CcSEcCtD
Clarithromycin—Infestation NOS—Temozolomide—brain cancer	0.000873	0.00249	CcSEcCtD
Clarithromycin—Depression—Temozolomide—brain cancer	0.00087	0.00249	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000865	0.00247	CcSEcCtD
Clarithromycin—Cardiac arrest—Etoposide—brain cancer	0.000862	0.00246	CcSEcCtD
Clarithromycin—Nausea—Lomustine—brain cancer	0.000861	0.00246	CcSEcCtD
Clarithromycin—Stomatitis—Temozolomide—brain cancer	0.000851	0.00243	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000839	0.0024	CcSEcCtD
Clarithromycin—Insomnia—Procarbazine—brain cancer	0.000833	0.00238	CcSEcCtD
Clarithromycin—Paraesthesia—Procarbazine—brain cancer	0.000827	0.00236	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Temozolomide—brain cancer	0.000825	0.00236	CcSEcCtD
Clarithromycin—Somnolence—Procarbazine—brain cancer	0.000818	0.00234	CcSEcCtD
Clarithromycin—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000816	0.00233	CcSEcCtD
Clarithromycin—Haemoglobin—Carmustine—brain cancer	0.000815	0.00233	CcSEcCtD
Clarithromycin—Haemorrhage—Carmustine—brain cancer	0.000811	0.00232	CcSEcCtD
Clarithromycin—Ill-defined disorder—Hydroxyurea—brain cancer	0.00081	0.00231	CcSEcCtD
Clarithromycin—Anaemia—Hydroxyurea—brain cancer	0.000807	0.0023	CcSEcCtD
Clarithromycin—Hallucination—Carmustine—brain cancer	0.000807	0.0023	CcSEcCtD
Clarithromycin—Decreased appetite—Procarbazine—brain cancer	0.0008	0.00229	CcSEcCtD
Clarithromycin—Alanine aminotransferase increased—Etoposide—brain cancer	0.000799	0.00228	CcSEcCtD
Clarithromycin—Connective tissue disorder—Carmustine—brain cancer	0.000797	0.00228	CcSEcCtD
Clarithromycin—Fatigue—Procarbazine—brain cancer	0.000794	0.00227	CcSEcCtD
Clarithromycin—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000793	0.0277	CbGpPWpGaD
Clarithromycin—Haemoglobin—Temozolomide—brain cancer	0.000787	0.00225	CcSEcCtD
Clarithromycin—Malaise—Hydroxyurea—brain cancer	0.000787	0.00225	CcSEcCtD
Clarithromycin—Pain—Procarbazine—brain cancer	0.000787	0.00225	CcSEcCtD
Clarithromycin—Constipation—Procarbazine—brain cancer	0.000787	0.00225	CcSEcCtD
Clarithromycin—Haemorrhage—Temozolomide—brain cancer	0.000783	0.00224	CcSEcCtD
Clarithromycin—Hepatitis—Temozolomide—brain cancer	0.000783	0.00224	CcSEcCtD
Clarithromycin—Leukopenia—Hydroxyurea—brain cancer	0.000781	0.00223	CcSEcCtD
Clarithromycin—Visual impairment—Carmustine—brain cancer	0.000781	0.00223	CcSEcCtD
Clarithromycin—Hallucination—Temozolomide—brain cancer	0.00078	0.00223	CcSEcCtD
Clarithromycin—Pharyngitis—Temozolomide—brain cancer	0.000778	0.00222	CcSEcCtD
Clarithromycin—Urinary tract disorder—Temozolomide—brain cancer	0.000774	0.00221	CcSEcCtD
Clarithromycin—Connective tissue disorder—Temozolomide—brain cancer	0.00077	0.0022	CcSEcCtD
Clarithromycin—Urethral disorder—Temozolomide—brain cancer	0.000768	0.00219	CcSEcCtD
Clarithromycin—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000763	0.0267	CbGpPWpGaD
Clarithromycin—Feeling abnormal—Procarbazine—brain cancer	0.000759	0.00217	CcSEcCtD
Clarithromycin—Eye disorder—Carmustine—brain cancer	0.000758	0.00216	CcSEcCtD
Clarithromycin—Convulsion—Hydroxyurea—brain cancer	0.000756	0.00216	CcSEcCtD
Clarithromycin—Visual impairment—Temozolomide—brain cancer	0.000755	0.00216	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Procarbazine—brain cancer	0.000753	0.00215	CcSEcCtD
Clarithromycin—Flushing—Carmustine—brain cancer	0.000752	0.00215	CcSEcCtD
Clarithromycin—Erythema multiforme—Temozolomide—brain cancer	0.000741	0.00212	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000738	0.00211	CcSEcCtD
Clarithromycin—Discomfort—Hydroxyurea—brain cancer	0.000734	0.0021	CcSEcCtD
Clarithromycin—Neutropenia—Etoposide—brain cancer	0.000732	0.00209	CcSEcCtD
Clarithromycin—Eye disorder—Temozolomide—brain cancer	0.000732	0.00209	CcSEcCtD
Clarithromycin—Urticaria—Procarbazine—brain cancer	0.000731	0.00209	CcSEcCtD
Clarithromycin—Tinnitus—Temozolomide—brain cancer	0.00073	0.00209	CcSEcCtD
Clarithromycin—Abdominal pain—Procarbazine—brain cancer	0.000728	0.00208	CcSEcCtD
Clarithromycin—Body temperature increased—Procarbazine—brain cancer	0.000728	0.00208	CcSEcCtD
Clarithromycin—Flushing—Temozolomide—brain cancer	0.000727	0.00208	CcSEcCtD
Clarithromycin—Cardiac disorder—Temozolomide—brain cancer	0.000727	0.00208	CcSEcCtD
Clarithromycin—Angiopathy—Temozolomide—brain cancer	0.000711	0.00203	CcSEcCtD
Clarithromycin—Mental disorder—Carmustine—brain cancer	0.00071	0.00203	CcSEcCtD
Clarithromycin—Infection—Hydroxyurea—brain cancer	0.000708	0.00202	CcSEcCtD
Clarithromycin—Immune system disorder—Temozolomide—brain cancer	0.000708	0.00202	CcSEcCtD
Clarithromycin—Mediastinal disorder—Temozolomide—brain cancer	0.000706	0.00202	CcSEcCtD
Clarithromycin—Malnutrition—Carmustine—brain cancer	0.000706	0.00202	CcSEcCtD
Clarithromycin—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000704	0.0246	CbGpPWpGaD
Clarithromycin—Chills—Temozolomide—brain cancer	0.000703	0.00201	CcSEcCtD
Clarithromycin—Pneumonia—Etoposide—brain cancer	0.000702	0.00201	CcSEcCtD
Clarithromycin—Nervous system disorder—Hydroxyurea—brain cancer	0.000699	0.002	CcSEcCtD
Clarithromycin—Infestation—Etoposide—brain cancer	0.000698	0.00199	CcSEcCtD
Clarithromycin—Infestation NOS—Etoposide—brain cancer	0.000698	0.00199	CcSEcCtD
Clarithromycin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000698	0.00199	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000692	0.00198	CcSEcCtD
Clarithromycin—Skin disorder—Hydroxyurea—brain cancer	0.000692	0.00198	CcSEcCtD
Clarithromycin—Renal failure—Etoposide—brain cancer	0.000687	0.00196	CcSEcCtD
Clarithromycin—Mental disorder—Temozolomide—brain cancer	0.000686	0.00196	CcSEcCtD
Clarithromycin—Back pain—Carmustine—brain cancer	0.000683	0.00195	CcSEcCtD
Clarithromycin—Malnutrition—Temozolomide—brain cancer	0.000682	0.00195	CcSEcCtD
Clarithromycin—Jaundice—Etoposide—brain cancer	0.000681	0.00194	CcSEcCtD
Clarithromycin—Stomatitis—Etoposide—brain cancer	0.000681	0.00194	CcSEcCtD
Clarithromycin—Anorexia—Hydroxyurea—brain cancer	0.000679	0.00194	CcSEcCtD
Clarithromycin—Hypersensitivity—Procarbazine—brain cancer	0.000678	0.00194	CcSEcCtD
Clarithromycin—Dysgeusia—Temozolomide—brain cancer	0.000668	0.00191	CcSEcCtD
Clarithromycin—Tremor—Carmustine—brain cancer	0.000661	0.00189	CcSEcCtD
Clarithromycin—Asthenia—Procarbazine—brain cancer	0.000661	0.00189	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Etoposide—brain cancer	0.00066	0.00189	CcSEcCtD
Clarithromycin—Back pain—Temozolomide—brain cancer	0.00066	0.00188	CcSEcCtD
Clarithromycin—Anaemia—Carmustine—brain cancer	0.000652	0.00186	CcSEcCtD
Clarithromycin—Agranulocytosis—Etoposide—brain cancer	0.000652	0.00186	CcSEcCtD
Clarithromycin—Pruritus—Procarbazine—brain cancer	0.000651	0.00186	CcSEcCtD
Clarithromycin—Agitation—Carmustine—brain cancer	0.000649	0.00185	CcSEcCtD
Clarithromycin—Tremor—Temozolomide—brain cancer	0.000639	0.00182	CcSEcCtD
Clarithromycin—Dyspnoea—Hydroxyurea—brain cancer	0.000635	0.00181	CcSEcCtD
Clarithromycin—Somnolence—Hydroxyurea—brain cancer	0.000633	0.00181	CcSEcCtD
Clarithromycin—Ill-defined disorder—Temozolomide—brain cancer	0.000633	0.00181	CcSEcCtD
Clarithromycin—Leukopenia—Carmustine—brain cancer	0.000632	0.0018	CcSEcCtD
Clarithromycin—Anaemia—Temozolomide—brain cancer	0.00063	0.0018	CcSEcCtD
Clarithromycin—Diarrhoea—Procarbazine—brain cancer	0.00063	0.0018	CcSEcCtD
Clarithromycin—Dyspepsia—Hydroxyurea—brain cancer	0.000627	0.00179	CcSEcCtD
Clarithromycin—Agitation—Temozolomide—brain cancer	0.000627	0.00179	CcSEcCtD
Clarithromycin—Angioedema—Temozolomide—brain cancer	0.000623	0.00178	CcSEcCtD
Clarithromycin—Decreased appetite—Hydroxyurea—brain cancer	0.000619	0.00177	CcSEcCtD
Clarithromycin—Urinary tract disorder—Etoposide—brain cancer	0.000619	0.00177	CcSEcCtD
Clarithromycin—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000618	0.0216	CbGpPWpGaD
Clarithromycin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000615	0.00176	CcSEcCtD
Clarithromycin—Malaise—Temozolomide—brain cancer	0.000615	0.00176	CcSEcCtD
Clarithromycin—Urethral disorder—Etoposide—brain cancer	0.000615	0.00176	CcSEcCtD
Clarithromycin—Fatigue—Hydroxyurea—brain cancer	0.000614	0.00175	CcSEcCtD
Clarithromycin—Vertigo—Temozolomide—brain cancer	0.000613	0.00175	CcSEcCtD
Clarithromycin—Convulsion—Carmustine—brain cancer	0.000611	0.00175	CcSEcCtD
Clarithromycin—Leukopenia—Temozolomide—brain cancer	0.000611	0.00174	CcSEcCtD
Clarithromycin—Pain—Hydroxyurea—brain cancer	0.000609	0.00174	CcSEcCtD
Clarithromycin—Constipation—Hydroxyurea—brain cancer	0.000609	0.00174	CcSEcCtD
Clarithromycin—Dizziness—Procarbazine—brain cancer	0.000609	0.00174	CcSEcCtD
Clarithromycin—Palpitations—Temozolomide—brain cancer	0.000603	0.00172	CcSEcCtD
Clarithromycin—Myalgia—Carmustine—brain cancer	0.000601	0.00172	CcSEcCtD
Clarithromycin—Chest pain—Carmustine—brain cancer	0.000601	0.00172	CcSEcCtD
Clarithromycin—Anxiety—Carmustine—brain cancer	0.000599	0.00171	CcSEcCtD
Clarithromycin—Cough—Temozolomide—brain cancer	0.000595	0.0017	CcSEcCtD
Clarithromycin—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000594	0.0208	CbGpPWpGaD
Clarithromycin—Erythema multiforme—Etoposide—brain cancer	0.000593	0.00169	CcSEcCtD
Clarithromycin—Convulsion—Temozolomide—brain cancer	0.000591	0.00169	CcSEcCtD
Clarithromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000589	0.0206	CbGpPWpGaD
Clarithromycin—Feeling abnormal—Hydroxyurea—brain cancer	0.000587	0.00168	CcSEcCtD
Clarithromycin—Eye disorder—Etoposide—brain cancer	0.000586	0.00167	CcSEcCtD
Clarithromycin—Vomiting—Procarbazine—brain cancer	0.000585	0.00167	CcSEcCtD
Clarithromycin—Flushing—Etoposide—brain cancer	0.000582	0.00166	CcSEcCtD
Clarithromycin—Cardiac disorder—Etoposide—brain cancer	0.000582	0.00166	CcSEcCtD
Clarithromycin—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000582	0.0203	CbGpPWpGaD
Clarithromycin—Confusional state—Carmustine—brain cancer	0.000581	0.00166	CcSEcCtD
Clarithromycin—Myalgia—Temozolomide—brain cancer	0.000581	0.00166	CcSEcCtD
Clarithromycin—Rash—Procarbazine—brain cancer	0.00058	0.00166	CcSEcCtD
Clarithromycin—Dermatitis—Procarbazine—brain cancer	0.00058	0.00166	CcSEcCtD
Clarithromycin—Anxiety—Temozolomide—brain cancer	0.000579	0.00165	CcSEcCtD
Clarithromycin—Headache—Procarbazine—brain cancer	0.000577	0.00165	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000577	0.00165	CcSEcCtD
Clarithromycin—Discomfort—Temozolomide—brain cancer	0.000574	0.00164	CcSEcCtD
Clarithromycin—Infection—Carmustine—brain cancer	0.000572	0.00163	CcSEcCtD
Clarithromycin—Angiopathy—Etoposide—brain cancer	0.000569	0.00162	CcSEcCtD
Clarithromycin—Dry mouth—Temozolomide—brain cancer	0.000568	0.00162	CcSEcCtD
Clarithromycin—Immune system disorder—Etoposide—brain cancer	0.000566	0.00162	CcSEcCtD
Clarithromycin—Mediastinal disorder—Etoposide—brain cancer	0.000565	0.00161	CcSEcCtD
Clarithromycin—Thrombocytopenia—Carmustine—brain cancer	0.000564	0.00161	CcSEcCtD
Clarithromycin—Body temperature increased—Hydroxyurea—brain cancer	0.000563	0.00161	CcSEcCtD
Clarithromycin—Chills—Etoposide—brain cancer	0.000563	0.00161	CcSEcCtD
Clarithromycin—Confusional state—Temozolomide—brain cancer	0.000561	0.0016	CcSEcCtD
Clarithromycin—Anaphylactic shock—Temozolomide—brain cancer	0.000557	0.00159	CcSEcCtD
Clarithromycin—Infection—Temozolomide—brain cancer	0.000553	0.00158	CcSEcCtD
Clarithromycin—Anorexia—Carmustine—brain cancer	0.000549	0.00157	CcSEcCtD
Clarithromycin—Nausea—Procarbazine—brain cancer	0.000547	0.00156	CcSEcCtD
Clarithromycin—Nervous system disorder—Temozolomide—brain cancer	0.000546	0.00156	CcSEcCtD
Clarithromycin—Thrombocytopenia—Temozolomide—brain cancer	0.000545	0.00156	CcSEcCtD
Clarithromycin—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000545	0.0191	CbGpPWpGaD
Clarithromycin—Skin disorder—Temozolomide—brain cancer	0.000541	0.00154	CcSEcCtD
Clarithromycin—Hyperhidrosis—Temozolomide—brain cancer	0.000538	0.00154	CcSEcCtD
Clarithromycin—Dysgeusia—Etoposide—brain cancer	0.000534	0.00153	CcSEcCtD
Clarithromycin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000531	0.0186	CbGpPWpGaD
Clarithromycin—Anorexia—Temozolomide—brain cancer	0.000531	0.00152	CcSEcCtD
Clarithromycin—Back pain—Etoposide—brain cancer	0.000528	0.00151	CcSEcCtD
Clarithromycin—Hypersensitivity—Hydroxyurea—brain cancer	0.000525	0.0015	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000525	0.0015	CcSEcCtD
Clarithromycin—Muscle spasms—Etoposide—brain cancer	0.000525	0.0015	CcSEcCtD
Clarithromycin—Insomnia—Carmustine—brain cancer	0.000521	0.00149	CcSEcCtD
Clarithromycin—Paraesthesia—Carmustine—brain cancer	0.000517	0.00148	CcSEcCtD
Clarithromycin—Dyspnoea—Carmustine—brain cancer	0.000514	0.00147	CcSEcCtD
Clarithromycin—Somnolence—Carmustine—brain cancer	0.000512	0.00146	CcSEcCtD
Clarithromycin—Asthenia—Hydroxyurea—brain cancer	0.000511	0.00146	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000507	0.00145	CcSEcCtD
Clarithromycin—Ill-defined disorder—Etoposide—brain cancer	0.000506	0.00145	CcSEcCtD
Clarithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000506	0.0177	CbGpPWpGaD
Clarithromycin—Anaemia—Etoposide—brain cancer	0.000504	0.00144	CcSEcCtD
Clarithromycin—Insomnia—Temozolomide—brain cancer	0.000503	0.00144	CcSEcCtD
Clarithromycin—Decreased appetite—Carmustine—brain cancer	0.000501	0.00143	CcSEcCtD
Clarithromycin—Paraesthesia—Temozolomide—brain cancer	0.0005	0.00143	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Carmustine—brain cancer	0.000497	0.00142	CcSEcCtD
Clarithromycin—Dyspnoea—Temozolomide—brain cancer	0.000496	0.00142	CcSEcCtD
Clarithromycin—Somnolence—Temozolomide—brain cancer	0.000495	0.00141	CcSEcCtD
Clarithromycin—Pain—Carmustine—brain cancer	0.000493	0.00141	CcSEcCtD
Clarithromycin—Constipation—Carmustine—brain cancer	0.000493	0.00141	CcSEcCtD
Clarithromycin—Malaise—Etoposide—brain cancer	0.000492	0.00141	CcSEcCtD
Clarithromycin—Vertigo—Etoposide—brain cancer	0.00049	0.0014	CcSEcCtD
Clarithromycin—Dyspepsia—Temozolomide—brain cancer	0.00049	0.0014	CcSEcCtD
Clarithromycin—Leukopenia—Etoposide—brain cancer	0.000489	0.0014	CcSEcCtD
Clarithromycin—Diarrhoea—Hydroxyurea—brain cancer	0.000488	0.00139	CcSEcCtD
Clarithromycin—Decreased appetite—Temozolomide—brain cancer	0.000484	0.00138	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Temozolomide—brain cancer	0.000481	0.00137	CcSEcCtD
Clarithromycin—Fatigue—Temozolomide—brain cancer	0.00048	0.00137	CcSEcCtD
Clarithromycin—Loss of consciousness—Etoposide—brain cancer	0.00048	0.00137	CcSEcCtD
Clarithromycin—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000478	0.0167	CbGpPWpGaD
Clarithromycin—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000477	0.0167	CbGpPWpGaD
Clarithromycin—Cough—Etoposide—brain cancer	0.000476	0.00136	CcSEcCtD
Clarithromycin—Pain—Temozolomide—brain cancer	0.000476	0.00136	CcSEcCtD
Clarithromycin—Constipation—Temozolomide—brain cancer	0.000476	0.00136	CcSEcCtD
Clarithromycin—Feeling abnormal—Carmustine—brain cancer	0.000475	0.00136	CcSEcCtD
Clarithromycin—Convulsion—Etoposide—brain cancer	0.000473	0.00135	CcSEcCtD
Clarithromycin—Dizziness—Hydroxyurea—brain cancer	0.000471	0.00135	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Carmustine—brain cancer	0.000471	0.00135	CcSEcCtD
Clarithromycin—Chest pain—Etoposide—brain cancer	0.000465	0.00133	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000461	0.00132	CcSEcCtD
Clarithromycin—Discomfort—Etoposide—brain cancer	0.000459	0.00131	CcSEcCtD
Clarithromycin—Feeling abnormal—Temozolomide—brain cancer	0.000459	0.00131	CcSEcCtD
Clarithromycin—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000459	0.016	CbGpPWpGaD
Clarithromycin—Abdominal pain—Carmustine—brain cancer	0.000455	0.0013	CcSEcCtD
Clarithromycin—Body temperature increased—Carmustine—brain cancer	0.000455	0.0013	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Temozolomide—brain cancer	0.000455	0.0013	CcSEcCtD
Clarithromycin—Vomiting—Hydroxyurea—brain cancer	0.000453	0.00129	CcSEcCtD
Clarithromycin—Rash—Hydroxyurea—brain cancer	0.000449	0.00128	CcSEcCtD
Clarithromycin—Confusional state—Etoposide—brain cancer	0.000449	0.00128	CcSEcCtD
Clarithromycin—Dermatitis—Hydroxyurea—brain cancer	0.000449	0.00128	CcSEcCtD
Clarithromycin—Headache—Hydroxyurea—brain cancer	0.000446	0.00127	CcSEcCtD
Clarithromycin—Anaphylactic shock—Etoposide—brain cancer	0.000445	0.00127	CcSEcCtD
Clarithromycin—Infection—Etoposide—brain cancer	0.000443	0.00126	CcSEcCtD
Clarithromycin—Urticaria—Temozolomide—brain cancer	0.000442	0.00126	CcSEcCtD
Clarithromycin—Abdominal pain—Temozolomide—brain cancer	0.00044	0.00126	CcSEcCtD
Clarithromycin—Body temperature increased—Temozolomide—brain cancer	0.00044	0.00126	CcSEcCtD
Clarithromycin—Thrombocytopenia—Etoposide—brain cancer	0.000436	0.00125	CcSEcCtD
Clarithromycin—Skin disorder—Etoposide—brain cancer	0.000433	0.00124	CcSEcCtD
Clarithromycin—Hyperhidrosis—Etoposide—brain cancer	0.000431	0.00123	CcSEcCtD
Clarithromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000426	0.0149	CbGpPWpGaD
Clarithromycin—Anorexia—Etoposide—brain cancer	0.000425	0.00121	CcSEcCtD
Clarithromycin—Hypersensitivity—Carmustine—brain cancer	0.000424	0.00121	CcSEcCtD
Clarithromycin—Nausea—Hydroxyurea—brain cancer	0.000423	0.00121	CcSEcCtD
Clarithromycin—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00042	0.0147	CbGpPWpGaD
Clarithromycin—Asthenia—Carmustine—brain cancer	0.000413	0.00118	CcSEcCtD
Clarithromycin—Hypersensitivity—Temozolomide—brain cancer	0.00041	0.00117	CcSEcCtD
Clarithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000404	0.0141	CbGpPWpGaD
Clarithromycin—Paraesthesia—Etoposide—brain cancer	0.0004	0.00114	CcSEcCtD
Clarithromycin—Asthenia—Temozolomide—brain cancer	0.000399	0.00114	CcSEcCtD
Clarithromycin—Dyspnoea—Etoposide—brain cancer	0.000397	0.00113	CcSEcCtD
Clarithromycin—Somnolence—Etoposide—brain cancer	0.000396	0.00113	CcSEcCtD
Clarithromycin—Diarrhoea—Carmustine—brain cancer	0.000394	0.00113	CcSEcCtD
Clarithromycin—Pruritus—Temozolomide—brain cancer	0.000394	0.00112	CcSEcCtD
Clarithromycin—Decreased appetite—Etoposide—brain cancer	0.000387	0.00111	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Etoposide—brain cancer	0.000385	0.0011	CcSEcCtD
Clarithromycin—Fatigue—Etoposide—brain cancer	0.000384	0.0011	CcSEcCtD
Clarithromycin—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000381	0.0133	CbGpPWpGaD
Clarithromycin—Dizziness—Carmustine—brain cancer	0.000381	0.00109	CcSEcCtD
Clarithromycin—Pain—Etoposide—brain cancer	0.000381	0.00109	CcSEcCtD
Clarithromycin—Constipation—Etoposide—brain cancer	0.000381	0.00109	CcSEcCtD
Clarithromycin—Diarrhoea—Temozolomide—brain cancer	0.000381	0.00109	CcSEcCtD
Clarithromycin—Dizziness—Temozolomide—brain cancer	0.000368	0.00105	CcSEcCtD
Clarithromycin—Feeling abnormal—Etoposide—brain cancer	0.000367	0.00105	CcSEcCtD
Clarithromycin—Vomiting—Carmustine—brain cancer	0.000366	0.00105	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Etoposide—brain cancer	0.000364	0.00104	CcSEcCtD
Clarithromycin—Rash—Carmustine—brain cancer	0.000363	0.00104	CcSEcCtD
Clarithromycin—Dermatitis—Carmustine—brain cancer	0.000363	0.00104	CcSEcCtD
Clarithromycin—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000362	0.0127	CbGpPWpGaD
Clarithromycin—Headache—Carmustine—brain cancer	0.000361	0.00103	CcSEcCtD
Clarithromycin—Vomiting—Temozolomide—brain cancer	0.000354	0.00101	CcSEcCtD
Clarithromycin—Urticaria—Etoposide—brain cancer	0.000354	0.00101	CcSEcCtD
Clarithromycin—Abdominal pain—Etoposide—brain cancer	0.000352	0.00101	CcSEcCtD
Clarithromycin—Body temperature increased—Etoposide—brain cancer	0.000352	0.00101	CcSEcCtD
Clarithromycin—Rash—Temozolomide—brain cancer	0.000351	0.001	CcSEcCtD
Clarithromycin—Dermatitis—Temozolomide—brain cancer	0.000351	0.001	CcSEcCtD
Clarithromycin—Headache—Temozolomide—brain cancer	0.000349	0.000996	CcSEcCtD
Clarithromycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000345	0.0121	CbGpPWpGaD
Clarithromycin—Nausea—Carmustine—brain cancer	0.000342	0.000977	CcSEcCtD
Clarithromycin—Nausea—Temozolomide—brain cancer	0.000331	0.000944	CcSEcCtD
Clarithromycin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000329	0.0115	CbGpPWpGaD
Clarithromycin—Hypersensitivity—Etoposide—brain cancer	0.000328	0.000937	CcSEcCtD
Clarithromycin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000327	0.0115	CbGpPWpGaD
Clarithromycin—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000325	0.0114	CbGpPWpGaD
Clarithromycin—Asthenia—Etoposide—brain cancer	0.00032	0.000913	CcSEcCtD
Clarithromycin—Pruritus—Etoposide—brain cancer	0.000315	0.0009	CcSEcCtD
Clarithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000312	0.0109	CbGpPWpGaD
Clarithromycin—Diarrhoea—Etoposide—brain cancer	0.000305	0.00087	CcSEcCtD
Clarithromycin—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000297	0.0104	CbGpPWpGaD
Clarithromycin—Dizziness—Etoposide—brain cancer	0.000295	0.000841	CcSEcCtD
Clarithromycin—Vomiting—Etoposide—brain cancer	0.000283	0.000809	CcSEcCtD
Clarithromycin—Rash—Etoposide—brain cancer	0.000281	0.000802	CcSEcCtD
Clarithromycin—Dermatitis—Etoposide—brain cancer	0.000281	0.000801	CcSEcCtD
Clarithromycin—Headache—Etoposide—brain cancer	0.000279	0.000797	CcSEcCtD
Clarithromycin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000267	0.00934	CbGpPWpGaD
Clarithromycin—Nausea—Etoposide—brain cancer	0.000265	0.000756	CcSEcCtD
Clarithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000257	0.00898	CbGpPWpGaD
Clarithromycin—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000254	0.00888	CbGpPWpGaD
Clarithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000253	0.00886	CbGpPWpGaD
Clarithromycin—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.00025	0.00876	CbGpPWpGaD
Clarithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000208	0.00728	CbGpPWpGaD
Clarithromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000207	0.00725	CbGpPWpGaD
Clarithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000198	0.00693	CbGpPWpGaD
Clarithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000195	0.00684	CbGpPWpGaD
Clarithromycin—SLC22A7—Fluoropyrimidine Activity—TP53—brain cancer	0.000194	0.0068	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—S100A10—brain cancer	0.000191	0.00668	CbGpPWpGaD
Clarithromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000185	0.00646	CbGpPWpGaD
Clarithromycin—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000183	0.00642	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000181	0.00633	CbGpPWpGaD
Clarithromycin—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000168	0.00588	CbGpPWpGaD
Clarithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000161	0.00562	CbGpPWpGaD
Clarithromycin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000149	0.00522	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000142	0.00496	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.00014	0.00489	CbGpPWpGaD
Clarithromycin—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000137	0.00479	CbGpPWpGaD
Clarithromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000129	0.00452	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000114	0.00399	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000111	0.00387	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000109	0.00381	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—PDGFRA—brain cancer	8.82e-05	0.00309	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—TRPC6—brain cancer	8.82e-05	0.00308	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	8.53e-05	0.00298	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	8.41e-05	0.00294	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	7.36e-05	0.00257	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	6.97e-05	0.00244	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	6.58e-05	0.0023	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	6.1e-05	0.00213	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.92e-05	0.00207	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	5.89e-05	0.00206	CbGpPWpGaD
Clarithromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	5.51e-05	0.00193	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.45e-05	0.00191	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	5.03e-05	0.00176	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	4.83e-05	0.00169	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL2—brain cancer	4.81e-05	0.00168	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	4.74e-05	0.00166	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	4.72e-05	0.00165	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	4.68e-05	0.00164	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.63e-05	0.00162	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.53e-05	0.00158	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.53e-05	0.00158	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	4.35e-05	0.00152	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP2C9—brain cancer	4.34e-05	0.00152	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.24e-05	0.00148	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	4.15e-05	0.00145	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—VEGFA—brain cancer	4.09e-05	0.00143	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.98e-05	0.00139	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—BSG—brain cancer	3.69e-05	0.00129	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	3.59e-05	0.00125	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	3.38e-05	0.00118	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—IDH1—brain cancer	3.17e-05	0.00111	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP2C9—brain cancer	3.14e-05	0.0011	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.1e-05	0.00109	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.82e-05	0.000985	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—BSG—brain cancer	2.67e-05	0.000933	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.62e-05	0.000917	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ENO2—brain cancer	2.51e-05	0.000878	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP2C9—brain cancer	2.43e-05	0.000849	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP2C9—brain cancer	2.37e-05	0.000828	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.32e-05	0.00081	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—IDH1—brain cancer	2.29e-05	0.000802	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.29e-05	0.000802	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—BSG—brain cancer	2.06e-05	0.000721	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.02e-05	0.000706	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—BSG—brain cancer	2.01e-05	0.000704	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP2C9—brain cancer	1.89e-05	0.000661	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.86e-05	0.00065	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.82e-05	0.000635	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ENO2—brain cancer	1.81e-05	0.000634	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—IDH1—brain cancer	1.77e-05	0.00062	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—IDH1—brain cancer	1.73e-05	0.000606	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—BSG—brain cancer	1.61e-05	0.000562	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.53e-05	0.000534	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP2C9—brain cancer	1.46e-05	0.00051	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.44e-05	0.000505	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ENO2—brain cancer	1.4e-05	0.00049	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—IDH1—brain cancer	1.38e-05	0.000483	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ENO2—brain cancer	1.37e-05	0.000479	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—BSG—brain cancer	1.24e-05	0.000434	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CG—brain cancer	1.15e-05	0.000403	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.13e-05	0.000394	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ENO2—brain cancer	1.09e-05	0.000382	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—IDH1—brain cancer	1.07e-05	0.000373	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ENO2—brain cancer	8.43e-06	0.000295	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CG—brain cancer	8.32e-06	0.000291	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CG—brain cancer	6.43e-06	0.000225	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CG—brain cancer	6.28e-06	0.00022	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CG—brain cancer	5.01e-06	0.000175	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CG—brain cancer	3.87e-06	0.000135	CbGpPWpGaD
